This B2B proposal integrates clean label formulations, sustainable packaging, and European quality standards without compromising scientific or regulatory rigor.
Sustainability, transparency, and efficiency have become key factors in the development of healthcare products. For this reason, Farmalider has launched Farmalider ECO, a new strategic platform focused on the development, licensing, and supply of solutions under a responsible innovation approach.
With this initiative, the company takes a step forward in its B2B model, offering pharmaceutical laboratories and international partners access to a portfolio designed to meet new market demands while maintaining the sector’s technical, regulatory, and quality standards.
Three pillars
Farmalider ECO is built on three fundamental pillars. First, clean label formulations, based on the rigorous selection of ingredients and the optimization of excipients, reducing non-essential components within the applicable regulatory framework.
Second, sustainable packaging, through the use of recyclable materials and solutions aimed at reducing environmental impact throughout the product lifecycle.
And finally, European quality standards, ensuring regulatory compliance, traceability, and industrial consistency.
This approach enables laboratories to integrate sustainability criteria into their portfolios without compromising safety, quality, or industrial feasibility.
Responding to market evolution
The launch of Farmalider ECO responds to several growing trends in the healthcare sector: increased demand for more transparent and simplified formulations; rising ESG and sustainability requirements; and the need for differentiation in mature categories.
In this context, Farmalider positions ECO as a platform that facilitates the transition toward more responsible development models, aligned with regulatory expectations and international market demands.
Sustainability embedded in the industrial model
Beyond the product itself, Farmalider ECO is supported by a cross-functional strategy that includes optimizing energy and resource consumption in production processes, as well as the progressive integration of renewable energy sources.
In addition, the company is developing solutions aligned with circular economy principles and incorporating ESG criteria into supplier selection and evaluation.
These initiatives are part of the company’s management and governance system, enabling continuous measurement, monitoring, and improvement of its environmental performance.
“Sustainability in the pharmaceutical industry cannot be approached as an isolated element. It must be integrated from product design through to manufacturing and supply. Farmalider ECO was created with this purpose: to deliver solutions that combine science, quality, and responsibility,” explains Marisa Berenguer, Chief Executive Officer of Farmalider.
Read more: Pharmatech
